1-(3-异丙基苯基)乙酮
|
I193260-250mg
|
≥98% |
40428-87-3 |
250mg
|
¥ 1199.9
|
期货,请咨询 |
阿拉丁 |
1-(3-异丙基苯基)乙酮
|
I193260-1g
|
≥98% |
40428-87-3 |
1g
|
¥ 3020.9
|
期货,请咨询 |
阿拉丁 |
DNA-PK抑制剂III
|
D337628-5mg
|
Moligand™, ≥95% |
404009-40-1 |
5mg
|
¥ 3706.9
|
现货 |
阿拉丁 |
DNA-PK抑制剂III
|
D337628-25mg
|
Moligand™, ≥95% |
404009-40-1 |
25mg
|
¥ 9268.9
|
现货 |
阿拉丁 |
3-氯-2-甲基异氰酸苯酯
|
C170174-250mg
|
≥98% |
40397-90-8 |
250mg
|
¥ 91.9
|
现货 |
阿拉丁 |
4'-(7-脱氯喹啉基)哌喹
|
D330672-500mg
|
≥95% |
4039-00-3 |
500mg
|
¥ 5767.9
|
期货,请咨询 |
阿拉丁 |
4'-(7-脱氯喹啉基)哌喹
|
D330672-250mg
|
≥95% |
4039-00-3 |
250mg
|
¥ 3604.9
|
期货,请咨询 |
阿拉丁 |
C₆₀MC₁₂
|
C153666-25mg
|
≥97%(HPLC) |
403483-19-2 |
25mg
|
¥ 925.9
|
现货 |
阿拉丁 |
4'-氟苯乙酮
|
F101384-2.5kg
|
≥98% |
403-42-9 |
2.5kg
|
¥ 889.9
|
现货 |
阿拉丁 |
4-(氨基甲基)-N,N-二乙基苯胺
|
A170169-250mg
|
≥97% |
40336-81-0 |
250mg
|
¥ 768.9
|
现货 |
阿拉丁 |
4-(氨基甲基)-N,N-二乙基苯胺
|
A170169-100mg
|
≥97% |
40336-81-0 |
100mg
|
¥ 494.9
|
现货 |
阿拉丁 |
4-氟三氯苄
|
F303661-5g
|
≥98% |
402-42-6 |
5g
|
¥ 99.9
|
现货 |
阿拉丁 |
4-氟三氯苄
|
F303661-500g
|
≥98% |
402-42-6 |
500g
|
¥ 3604.9
|
现货 |
阿拉丁 |
4-氟三氯苄
|
F303661-25g
|
≥98% |
402-42-6 |
25g
|
¥ 418.9
|
现货 |
阿拉丁 |
4-氟三氯苄
|
F303661-1kg
|
≥98% |
402-42-6 |
1kg
|
¥ 5870.9
|
现货 |
阿拉丁 |
4-氟三氯苄
|
F303661-100g
|
≥98% |
402-42-6 |
100g
|
¥ 925.9
|
现货 |
阿拉丁 |
Philanthotoxin-7,4 (PhTx-74) (mM/ml),GluA1 / GluA2抑制剂
|
P276208-20mM-ml
|
≥98% |
401601-12-5 |
20mM/ml
|
¥ 1050.9
|
期货,请咨询 |
阿拉丁 |
N'-(1-(苯并[D][1,3]二氧戊环-5-基)亚乙基)-4-甲基苯磺酰肼
|
N419572-5g
|
≥95% |
401595-24-2 |
5g
|
¥ 838.9
|
期货,请咨询 |
阿拉丁 |
N'-(1-(苯并[D][1,3]二氧戊环-5-基)亚乙基)-4-甲基苯磺酰肼
|
N419572-250mg
|
≥95% |
401595-24-2 |
250mg
|
¥ 88.9
|
期货,请咨询 |
阿拉丁 |
N'-(1-(苯并[D][1,3]二氧戊环-5-基)亚乙基)-4-甲基苯磺酰肼
|
N419572-1g
|
≥95% |
401595-24-2 |
1g
|
¥ 233.9
|
期货,请咨询 |
阿拉丁 |
氟碘乙酸乙酯
|
E331038-1g
|
≥98% |
401-58-1 |
1g
|
¥ 472.9
|
现货 |
阿拉丁 |
5-甲氧基吡嗪-2-羧酸
|
M339526-5g
|
≥96% |
40155-42-8 |
5g
|
¥ 135.9
|
现货 |
阿拉丁 |
5-甲氧基吡嗪-2-羧酸
|
M339526-25g
|
≥96% |
40155-42-8 |
25g
|
¥ 602.9
|
现货 |
阿拉丁 |
5-甲氧基吡嗪-2-羧酸
|
M339526-1g
|
≥96% |
40155-42-8 |
1g
|
¥ 36.9
|
现货 |
阿拉丁 |